It should be noted that MTC is rare (estimated incidence of 0.2 cases per 100,000 patient-years), and as such, it is very difficult to definitively rule out an association between GLP-1RA and thyroid malignancies
Tirzepatide produced greater mean weight loss and larger reductions in waist circumference than semaglutide over comparable time frames as a clinical confirmation of the dual-agonists potency
Tirzepatide which targets both GLP-1 and GIP receptors has shown even more dramatic early results: weight loss of 1020 kg and insulin dose reductions exceeding 30% in observational and phase 2 data, with improved CGM time in range
In the long term, it can lead to sarcopeniaage-related muscle losswhich increases the risk of falls, fractures, and other mobility issues
He is 42 years old, currently weighs 235 pounds, and his goal weight is 185 pounds